Compare AKA & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKA | ORMP |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4M | 141.3M |
| IPO Year | 2021 | 2010 |
| Metric | AKA | ORMP |
|---|---|---|
| Price | $10.34 | $3.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | 2.6K | ★ 89.6K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.54% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 1.50 |
| Revenue | ★ $600,208,000.00 | $2,000,000.00 |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $4.89 | N/A |
| P/E Ratio | ★ N/A | $2.55 |
| Revenue Growth | 4.44 | ★ 49.25 |
| 52 Week Low | $7.00 | $1.98 |
| 52 Week High | $16.38 | $3.91 |
| Indicator | AKA | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 68.49 |
| Support Level | $8.94 | $3.21 |
| Resistance Level | $10.53 | N/A |
| Average True Range (ATR) | 0.54 | 0.17 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 46.31 | 94.12 |
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.